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Ambient Air Pollution and Mortality in 652 Cities
To the Editor: In response to the article by Liu 
et al. (Aug. 22 issue)1: the inhalable fraction of 
particulate matter with an aerodynamic diameter 
of 10 μm or less (PM10) in the real world is made 
up of a mixture of substances probably derived 
from many sources.2 In urban areas, a substan-
tial fraction of PM10 is related to combustion 
emissions (transport, industry, power generation, 
and the like).3 However, in arid regions, a large 
fraction of PM10 derives from desert dust parti-
cles. This kind of PM10, emitted from the soil of 
deserts and transported by the action of wind, 
causes dust storms that are common in North 
Africa, the Middle East, and inner Asia and that 
occur occasionally in Mediterranean countries 
and the North Atlantic. The global effect is poor 
air quality for more than 2 billion people.4
The influence of PM10 that is derived from 
combustion on cardiovascular pathophysiology 
is different from the influence of PM10 derived 
from dust.5 This differentiation should be con-
sidered in global studies that have included 
regions affected by desert dust, such as inner 
Asia (Fig. 1); studies need to be done to deter-
mine the causal components in particulate 
matter.
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Figure 1. Dust Intrusion from the Gobi Desert into China.
Marked cities were part of the study by Liu et al.1 Image from the Land, At-
mosphere Near real-time Capability for EOS (LANCE) system operated by 
the NASA Earth Science Data and Information System (ESDIS).
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To the Editor: Liu et al. claim that poor air 
quality, due to increased particulate matter, in 
more than 600 cities across the world can be 
linked to mortality. We question the reliability of 
this claim given negative studies1,2 and reanalysis 
of two meta-analytic studies3,4 in which the re-
analysis attempts to vitiate the conclusion of the 
source studies that particulate matter causes 
heart attacks. With respect to Liu et al., 16 P val-
ues that we computed from data regarding fine 
particulate matter with an aerodynamic diameter 
of 2.5 μm or less (PM2.5) in Table 1 of their article 
lead to a striking P-value plot: 8 values along a 
roughly 45-degree line are consistent with the 
lack of a causal association, whereas 8 are less 
than 0.05, supporting an association (Fig. 1). In 
effect, we think that Liu et al. reported data from 
studies that form a two-component mixture, as 
observed in two recent reports3,4; we think it 
makes no sense to report an average based on a 
mixture having two components.
S. Stanley Young, Ph.D.
CGStat 
Raleigh, NC 
genetree@ bellsouth . net
Warren Kindzierski, Ph.D.
University of Alberta 
Edmonton, AB, Canada
No potential conflict of interest relevant to this letter was re-
ported.
1. Milojevic A, Wilkinson P, Armstrong B, Bhaskaran K, 
Smeeth L, Hajat S. Short-term effects of air pollution on a range 
of cardiovascular events in England and Wales: case-crossover 
analysis of the MINAP database, hospital admissions and mor-
tality. Heart 2014; 100: 1093-8.
2. Young SS, Smith RL, Lopiano KK. Air quality and acute 
deaths in California, 2000-2012. Regul Toxicol Pharmacol 2017; 
88: 173-84.
3. Young SS, Acharjee MK, Das K. The reliability of an environ-
mental epidemiology meta-analysis, a case study. Regul Toxicol 
Pharmacol 2019; 102: 47-52.
4. Young SS, Kindzierski WB. Evaluation of a meta-analysis of 
air quality and heart attacks, a case study. Crit Rev Toxicol 2019; 
49: 85-94.
DOI: 10.1056/NEJMc1913285
To the Editor: Liu et al. found consistent in-
creases in daily all-cause, cardiovascular, and 
respiratory mortality in association with in-
creasing concentrations of ambient particulate 
matter in 652 cities worldwide. We caution that 
future studies should not consider populations 
of individual cities as a static entity. Cities are 
increasingly connected, currently with 1.2 bil-
lion international arrivals per year.1 Cities, their 
residents, their visitors, and their temporary 
residents do not represent a constant cohort but 
present dynamic interdependent systems in 
concert with variable pollution profiles. The 
health effects that are observed in an individ-
ual’s usual residence city might be more asso-
ciated with exposures in a frequent destina-
tion city or temporary residence city. Even 
short-stay international travel to cities with 
 elevated air pollution by healthy adults has 
now been associated with adverse cardiopulmo-
nary health effects, including decreased lung 
function and heart-rate variability and an in-
crease in respiratory symptoms.2 Future research 
should consider mobile sectors of the popula-
tion when studying air pollution–related health 
outcomes. Municipal authorities should be re-
sponsible for the health of their residents and 
visitors.
Figure 1. Plot of P Values.
In this plot, P values for the association between fine 
particulate matter with an aerodynamic diameter of 
2.5 μm or less and all-cause mortality are ranked from 
smallest to largest and plotted against the integers 1 
through 16. Each P value corresponds to one country 
listed in Table 1 of the article by Liu et al. The dashed 
line at 0.05 represents nominal statistical significance.
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To the Editor: The editorial by Balmes1 regard-
ing the 652-city study of air pollution by Liu et al. 
cites an article in Science2 that states that I want to 
rely on studies that use a theoretical approach 
called “manipulative causality” as the basis for 
regulatory decision making, thereby restricting 
epidemiologic evidence considered in assessing 
causality. Neither article correctly paraphrases 
my views. The Clean Air Scientific Advisory Com-
mittee recently asked for a “clearer discussion of 
causality.”3 My personal view is that the weight-
of-evidence approach of the Environmental Pro-
tection Agency (EPA) does not offer a clear defi-
nition for causality in studies of air pollution. I 
think that the EPA should specifically character-
ize the types of harm to human health that are 
preventable or can be lessened by reducing expo-
sures to particulate matter (manipulative causa-
tion), since this is ultimately what could matter 
most to policymakers.4 Balmes opines that this 
“would set a dangerous precedent for environ-
mental policy.” I seek clarity in the definition of 
causality in studies of air pollution, not restric-
tions on the evidence considered.
Louis A. Cox, Jr., Ph.D.
University of Colorado 
Denver, CO 
tcoxdenver@ aol . com
No potential conflict of interest relevant to this letter was re-
ported.
1. Balmes JR. Do we really need another time-series study of 
the PM2.5-mortality association? N Engl J Med 2019; 381: 774-6.
2. Goldman GT, Dominici F. Don’t abandon evidence and pro-
cess on air pollution policy. Science 2019; 363: 1398-400.
3. Cox LA Jr. Letter to Honorable Andrew R. Wheeler regarding 
CASAC review of the EPA’s integrated science assessment for 
particulate matter (external review draft — October 2018). April 
2019 (https://yosemite .epa .gov/ sab/ sabproduct .nsf/ LookupWeb 
ReportsLastMonthCASAC/ 6CBCBBC3025E13B4852583D90047B 
352/ %24File/ EPA - CASAC - 19 - 002+ .pdf).
4. Burns J, Boogaard H, Polus S, et al. Interventions to reduce 
ambient particulate matter air pollution and their effect on 
health. Cochrane Database Syst Rev 2019; 5: CD010919.
DOI: 10.1056/NEJMc1913285
The authors reply: Hernandez-Vaquero et al. 
raise a point regarding the identification of the 
causal components for mortality within inhal-
able particulate matter. We agree that the toxicity 
of particulate matter may vary with respect to 
different sources (such as combustion emissions 
and desert dust), and the composition of particu-
late matter is a potential source of heterogeneity 
in our study. More data are needed to expand our 
understanding of this link in inner Asia or the 
Middle East, where desert dust is the main con-
tributor to inhalable particulate matter.
The comments by Young and Kindziersky are 
based on a biased summary of the literature and 
a misunderstanding of the study design that we 
used. First, the link between exposure to particu-
late matter and a short-term increase in mortal-
ity is firmly established from dozens of large-
scale, multicenter epidemiologic investigations 
and reports worldwide.1-3 This evidence cannot be 
dismissed by two small studies that assessed 
only cardiovascular events or were conducted in 
limited locations. More important, the authors did 
not acknowledge that our study is not a meta-
analysis, but a multilocation study with direct data 
collection in 652 cities. The risks that we report 
in Table 1 of our article therefore do not repre-
sent previously published estimates, but country-
specific effects pooled from multiple cities directly 
measured with the use of a two-stage design. 
Thus, none of their arguments related to publica-
tion bias, “P-hacking,” and subpopulations actu-
ally applies. Finally, the fact that some P values are 
above the significance threshold is expected, given 
the uncertainty of single estimates inherent in 
multicenter studies or related to the small data 
sets available from some regions. Our pooled 
estimates, however, indicate strong evidence of 
an association, with values that are consistent 
with those of most previous studies.
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Vilcassim et al. raise an issue of uncertainty 
from traveling or migration and proposed to pay 
attention to the health effects of air pollution 
among the mobile sector of the population. 
However, few natural deaths are expected to oc-
cur among active travelers; we cannot account 
for in-migration or out-migration, but the num-
bers are probably small compared with deaths in 
the resident population.
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The editorialist replies: Cox expounds that 
the weight-of-evidence approach of the EPA does 
not offer a clear definition for causality; I dis-
agree. The previously established approach of the 
EPA combines evidence from epidemiologic stud-
ies, human experimental studies, and toxicologic 
studies in animals to causally link exposure to an 
environmental hazard and a health outcome. Al-
though Cox favors studies that involve manipula-
tive causation, these are not feasible in large-
scale, multi-city studies of air pollution. In such 
settings, the Bradford Hill guidelines for infer-
ence of causation from observational studies are 
standard.1 These guidelines include strength of 
association, consistency, specificity, temporality, 
biologic gradient, plausibility, coherence, experi-
mental evidence, and analogy. Although the evi-
dence for the PM2.5–mortality association meets 
all of these guidelines, Cox does not accept 
them.2,3 The proven weight-of-evidence approach 
of the EPA is explicitly based on the Bradford Hill 
guidelines, which were used to establish the link 
between smoking and lung cancer, and is en-
dorsed by the American Thoracic and European 
Respiratory Societies and the National Research 
Council.4,5 We should not discard this time-tested 
approach to abet Cox’s efforts to obfuscate our 
knowledge that PM2.5 can cause death.
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Oral Semaglutide and Cardiovascular Outcomes in Type 2 
Diabetes
To the Editor: Preventive strategies for cardio-
vascular complications in type 2 diabetes melli-
tus are essential. Subcutaneous glucagon-like 
peptide-1 (GLP-1) receptor agonists have signifi-
cantly reduced cardiovascular risk in four of six 
published outcome trials.1,2 In the Peptide Inno-
vation for Early Diabetes Treatment (PIONEER) 6 
trial (Aug. 29 issue),3 the first oral GLP-1 receptor 
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